Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...

There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain ...

Current health news highlights include UK investor backing in Assura's acquisition by PHP, Novo Nordisk's legal affairs over Wegovy drug sales, and Apollo Hospitals' increased AI investments. The CDC ...

Women who took part in a weight loss programme had a 21 per cent higher chance of becoming pregnant – whether naturally or ...

In India, home to 74 million diabetes patients, a range of supplements is being marketed as natural GLP-1 alternatives, but ...

New research suggests popular weight loss drugs like Ozempic and Wegovy may affect more than just fat, raising questions ...

(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...

On July 14, 2025, the operators of telemedicine company Southern Health Solutions, Inc., doing business as Next Medical and ...

This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...

A large-scale cohort study has found that GLP-1s, including Ozempic and Wegovy, may be associated with a modestly increased risk of developing diabetic retinopathy. The research, published Aug. 11 in ...

Portion sizes have been getting bigger and bigger for years, so it's no bad thing that the rise of fat jabs is forcing ...